Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.


Chemotherapy Foundation Symposium Overview

June 24th 2010

2008's Chemotherapy Foundation Symposium

Reporting from the Chemotherapy Foundation Symposium

June 23rd 2010

In this month's issue of Oncology & Biotech News, we report on the Chemotherapy Foundation Symposium, which was held in New York City. This excellent meeting highlighted emerging therapies in cancer treatment and the ways in which these treatments are changing our views and management of cancer.

Reimbursement and Managed Care News for February 2008

June 23rd 2010

Topics covered in this issue include: 1) A Need to Better Manage Use of CT Scans to Avoid Excess Cancer Risk? 2) Fuller Disclosure in Doctor-Ranking Models Nationwide 3) Which Is More Cost Effective: Rituximab or Stem-Cell Transplant for Follicular Lymphoma? 4) Colorectal Cancer Screening in Medicare Patients Still Largely Ignored 5) Does Quality of Life Vary Among Chemotherapies in Advanced Non-Small Cell Lung Cancer? 6) Insurer and Oncology Group Begin Pay-for-Performance Arrangement 7) Patients With Health Insurance Have Better Cancer Outcomes

Physicians' Financial News: February 2008

June 23rd 2010

Physicians' Financial News focuses on news-making and/or notable companies in the oncology/biotech sector. In this issue: Millennium Pharmiceuticals, Inc.: Future Looking Bright After Record 2007 Eisai Co., Ltd.: Eisai Purchases MGI Pharma Amgen, Inc.: Denosumab Linked With Increased Bone Density in Breast Cancer Patients Genzyme Corporation: Thyrogen Captures New Thyroid Cancer� Related Indication

Fast Facts

June 23rd 2010

A collection of cancer statistics and facts.

Februrary 2008 Clinical Trial Reports

June 23rd 2010

The Clinical Trials reported in this issue include: PHASE III: 1) What Factors Predict Prognosis in Patients With Malignant Pleural Mesothelioma? 2) Treatment for Patients With High-Risk Postoperative Breast Cancer PHASE II: 1) Epratuzumab Plus Rituximab Equals Non-Hodgkin's Lymphoma Response 2) Topotecan Added to Twice-Daily Chemoradiation to Treat Limited- Stage, Small-Cell Lung Cancer 3) First-Line Therapy for Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer 4) Radiotherapy for Nasal Squamous Cell Carcinoma Therapy PHASE I/II: 1) A New Combination Approach for Advanced-Stage Germ-Cell Tumors

Clinical Abstracts From Overseas: June 23, 2010

June 23rd 2010

Articles in this issue include: 1) South Korea: Is Intermittent Imatinib Therapy for Chronic Myelogenous Leukemia an Option? Genetic Marker Predicts Treatment Resistance and Poor Outcomes in Esophageal Cancer 2) France: Pelvic Radiation in Addition to Prostate Radiotherapy for Localized Prostate Cancer 3) Multiple Sites in Europe: European Guidelines for Oral Mucositis Released 4) Japan: The Care of Delirium in Terminal Illness and Bereavement Needs 5) The Netherlands: Cancer Pain and Adherence to Analgesic Treatment 6) Switzerland, Belgium & France: Confirmation of Gene Expression Link to Chemotherapy Response in Breast Cancer

OncLive News Briefs: June 22, 2010

June 22nd 2010

1) Lenalidomide (Revlimid) has been granted orphan medicinal product designation by the European Commission (EC) for treatment of chronic lymphocytic leukemia (CLL). 2) Treatment With Cetuximab May Enable Complete Surgical Resection of Colorectal Liver Metastases

Short-Term Hormone Therapy May Slow Prostate Cancer

June 22nd 2010

New research suggests that a common but controversial treatment for prostate cancer reduces long-term death rates without greatly boosting patients' risk of heart problems.

American Society of Hematology Meeting Highlights

June 22nd 2010

The American Society of Hematology (ASH) held its 49th Annual Meeting at the Georgia World Congress Center in Atlanta in December. The following reports provide summary coverage of meeting highlights, primarily focusing upon notable research breakthroughs relating to hematological malignancies.

Focusing on Hematological Malignancies

June 22nd 2010

This month we report from the American Society of Hematology's 49th Annual Meeting, which took place in Atlanta. Our pages provide summary coverage of meeting highlights, primarily focusing on notable research breakthroughs relating to hematological malignancies, including advances in multiple myeloma, leukemia, and lymphoma. Our regular columns--Global Reports, Clinical Trial Reports, Physicians' Financial News, and Reimbursement and Managed Care--offer practicing oncologists perspectives needed to keep current in the industry.

Physicians' Financial News: March 2008

June 21st 2010

Physicians' Financial News focuses on news-making and/or notable companies in the oncology biotechnology sector. In this issue: Novartis: Novartis Leverages Formidable Size and Pipeline to Maintain Strong Oncology Position Roche AG: Ventana Medical Systems Taken Over by Roche Schering Plough: Potential Melanoma Treatment Granted Priority Review Amgen: Studies Suggest Expanded Role for Vectibix in Colorectal Cancer OxiGene: Potential Platinum-Resistant Ovarian Cancer Treatment Hits a Key Phase II Target

The Academy: June 21, 2010

June 21st 2010

The Academy delivers the latest news on biotech and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery. In this issue: 1) University of California, San Francisco: Novel Mapping Technique Has Potential to Improve Brain Surgery 2) Indiana University School of Medicine: Combination of Taxol and Avastin Yields Robust Results for Breast Cancer 3) M.D. Anderson Cancer Center, The University of Texas: New Test Has Potential To Heighten Myelodysplastic Syndrome Assessment Accuracy 4) James P. Wilmot Cancer Center,University of Rochester Medical Center: Alternate Lymphoma Option Shows Promise 5) The Hormel Institute, University of Minnesota: Cell Line Research Further Affirms Obesity as a Breast Cancer Risk Factor

Reimbursement and Managed Care News for March 2008

June 21st 2010

Topics covered in this issue include: 1) National Managed Care Plans Stop Paying for Anesthetic in Colonoscopy 2) Managed Care Organizations Will not Pay for Care Resulting From Preventable Errors 3) Is Progression-Free Survival a Real Clinical Benefit? 4) Do Practice Patterns Reflect National Recommendations in Gallbladder Cancer? 5) National HMO Bases Chemotherapy Coverage on Guideline Compendium 6) Pap Test Screening: Better Testing Versus More Frequent Office Visits 7) CMS Issues Instructions for EPO Claims Reporting

March 2008 Clinical Trial Reports

June 21st 2010

The Clinical Trials reported in this issue include: PHASE III: 1) Central Nervous System Stimulant for Brain Tumors 2) Paclitaxel and Carboplatin Treatment for Patients With Lung Cancer 3) The 100-Month Analysis of the ATAC Trial 4) Radical Nephrectomy not as Beneficial as Partial Nephrectomy for Small Renal Tumors in Younger Populations 5) Combination Therapy Reduces Prostate Cancer Death Rates 6) Bortezomib Produced Significant Complete Remission Rates in Front-Line Multiple Myeloma Trial PHASE II: 1) Subcutaneous Amifostine Treatment for Head and Neck Carcinoma

Clinical Abstracts From Overseas: June 18, 2010

June 18th 2010

Articles in this issue include: United Kingdom: The Pill's Anti-Ovarian Cancer Effect Lasts for Decades The Netherlands: Catheter-Related Infection Prevention Improves With Specialized Rinse Italy: Obesity May Help Survival in Women Who Have Endometrial Cancer Germany: One-Two Punch for B-cell Lymphoma in the Elderly South Korea: Predicting Survival by Counting Metastatic Lymph Nodes Poland: Do Chest X-Rays in Young Women Raise the Risk of Breast Cancer? Australia: Concurrent or Sequential Anthracycline and Docetaxel?

OncLive News Briefs: June 18, 2010

June 18th 2010

In this issue: Bortezomib (Velcade) Granted Priority Review Status for Patients With Newly Diagnosed Multiple Myeloma Reports from American Society of Hematology: Advances in Thrombosis: (1) AMG 531 Demonstrates Efficacy in Sustaining Platelet Counts in Splenectomized Patients With Chronic Immune Thrombocytopenic Purpura in Phase III Study (2) Low–Molecular-Weight Heparin Reduces the Cost of Venous Thromboembolism Treatment Compared With Unfractionated Heparin

Resisting Lung Cancer Recurrence

June 18th 2010

What if lung cancer recurrence could be prevented for years after surgery by giving simple recall injections every two years?

Highlighting Advances in Breast Cancer

June 18th 2010

The 30th Annual Charles A. Coltman, Jr. San Antonio Breast Cancer Symposium (SABCS) was held December 13-16, 2007, at the Henry B. Gonzalez Convention Center, San Antonio, Texas. Our editors highlight the newest research and emerging trends in treatment and care.

Highlights from the San Antonio Breast Cancer Symposium

June 18th 2010

In this issue, Oncology & Biotechnology News' editors focus on the 30th Annual San Antonio Breast Cancer Symposium (SABCS), held in December. In addition,such departments and monthly columns as Physicians' Financial News, Global Reports, Clinical Trial Reports, The Academy, and Reimbursement and Managed Care News offer the practicing oncologist the perspectives needed to keep abreast of the industry.

NEXT PAGE
PREVIOUS PAGE